Rhythm Pharmaceuticals, Inc. RYTM
98.66
0.35
0.36%
as of 25 Sep
- Market cap
- $6.8B
- P/E
- 0.0×
Follow RYTM
Growth Flags
show if company had growth for consecutive years
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | — | — | — | — | 156.95 | 63.15 | 33.62 | 26.24 | 36.66 |
P/FCF ratio |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | — | — | (12.23) | (43.90) | (88.58) | (181.19) | (273.97) |
P/B ratio |
— | — | — | — | — | 1.74 | 5.65 | 15.33 | 157.14 | 50.02 |
Price to Tangible BV |
— | — | — | — | — | 1.77 | 5.82 | 15.99 | 219.51 | 52.01 |
EV/Sales |
— | — | — | — | — | 63.46 | 49.05 | 30.05 | 23.78 | 34.61 |
EV/EBITDA |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | — | — | (1.37) | (6.69) | (17.09) | (27.17) | (56.77) |
EV/FCF |
— | — | — | — | — | (1.39) | (6.79) | (15.95) | (19.53) | (40.76) |
Quick Ratio |
2.23 | 22.04 | 18.56 | 11.98 | 9.60 | 6.81 | 8.53 | 5.27 | 2.94 | 3.92 |
Current Ratio |
2.36 | 22.42 | 19.05 | 12.39 | 10.10 | 7.10 | 8.90 | 5.58 | 3.24 | 4.41 |
Net Debt/EBITDA |
0.41 | 4.60 | 3.23 | 2.01 | 1.27 | 1.75 | 1.88 | 1.51 | 1.21 | 2.04 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.07 | 0.22 | 0.36 | 0.44 |
Operating CF/Net income |
0.80 | 0.78 | 0.84 | 0.87 | 0.91 | 2.10 | 0.96 | 0.74 | 0.43 | 0.57 |
Capex/Depreciation |
(7.34) | (0.60) | (1.63) | (4.06) | (0.31) | 1.35 | (2.56) | (3.25) | (25.91) | (30.61) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 142.86% | (67.06%) | (37.88%) | (53.38%) | (59.88%) | (30.89%) | (66.05%) | (85.10%) | (276.33%) | (251.14%) | |
| (117.20%) | (45.81%) | (35.96%) | (49.49%) | (54.07%) | (26.95%) | (50.88%) | (51.64%) | (72.98%) | (46.29%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(394.28%) | (25.96%) | (30.08%) | (49.96%) | (80.30%) | (26.00%) | (57.20%) | (72.59%) | (102.03%) | (55.77%) |
Average Days of Receivables |
— | — | — | — | — | 118.62 | 96.11 | 70.08 | 51.93 | 50.17 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3,301.46% | 459.56% | 174.29% | 182.87% | 88.19% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2,171.40% | 389.34% | 151.80% | 110.90% | 102.73% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 659.61% | 83.89% | 42.04% | 30.50% | 35.21% |
Graham Net Nets |
— | — | — | — | — | 0.53 | 0.16 | 0.06 | 0.04 | 0.04 |
Graham Number |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | — | — | (13.33%) | (12.15%) | (7.09%) | (7.77%) | (2.91%) |
Free Cash Flow Yield |
— | — | — | — | — | (29.18%) | (11.44%) | (5.60%) | (4.64%) | (2.32%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.45 | 1.34 | 2.13 | 2.92 |
Operating CF per Share |
(2.28) | (2.22) | (2.00) | (3.37) | (2.76) | (2.94) | (3.33) | (2.36) | (1.87) | (1.78) |
Capex per Share |
(0.10) | (0.01) | (0.02) | (0.09) | 0.00 | 0.03 | (0.08) | (0.10) | (0.66) | (0.63) |
Free Cash Flow per Share |
(2.38) | (2.23) | (2.02) | (3.46) | (2.77) | (2.91) | (3.41) | (2.46) | (2.53) | (2.41) |
Cash per Share |
1.03 | 11.16 | 8.13 | 8.03 | 3.92 | 5.94 | 6.39 | 4.78 | 5.26 | 5.99 |
Shareholders Equity per Share |
0.72 | 10.91 | 7.94 | 7.72 | 3.77 | 5.73 | 5.07 | 2.94 | 2.70 | 4.16 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.72 | 10.91 | 7.94 | 7.72 | 3.77 | 5.73 | 5.07 | 2.94 | 2.70 | 4.16 |
Free Cash Flow |
(24.28) | (29.59) | (62.78) | (126.13) | (122.19) | (144.44) | (177.71) | (141.87) | (154.38) | (156.63) |
Working Capital |
6.44 | 143.95 | 245.11 | 277.99 | 163.67 | 264.96 | 314.43 | 253.07 | 258.68 | 360.97 |
Capital Expenditures |
(1.06) | (0.13) | (0.72) | (3.38) | (0.21) | 1.57 | (4.28) | (5.71) | (40.50) | (40.95) |
Net Current Asset Value |
6.13 | 143.72 | 244.74 | 274.90 | 161.12 | 263.02 | 236.02 | 145.28 | 146.48 | 256.75 |
EV/EBIT |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.50) | 0.18 | 0.07 | 0.31 | 0.22 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (2,207.10%) | (766.22%) | (238.52%) | (203.32%) | (106.41%) |
Price to Operating Income |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.15 | 0.27 | 0.39 | 0.23 | 0.22 | 0.41 | 0.76 | 1.31 | 2.47 | 1.21 |
Cash ROIC |
(135.41%) | (10.35%) | (12.68%) | (22.04%) | (36.89%) | (25.70%) | (29.39%) | (30.86%) | (23.60%) | (17.72%) |
Accounts Receivable Turnover |
— | — | — | — | — | 0.00 | 6.52 | 7.34 | 7.80 | 8.51 |
Accounts Payable Turnover |
0.09 | 0.10 | 0.09 | 0.09 | 0.09 | 0.11 | 0.41 | 1.92 | 1.55 | 1.48 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.41 | 1.61 | 0.98 | 0.88 |
Average Days of Payables |
4,803.30 | 3,972.44 | 6,309.05 | 4,558.12 | 2,592.03 | 3,495.83 | 820.87 | 191.68 | 336.60 | 261.17 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 67.64 | 499.16 | 338.40 | 511.70 | 482.24 |
Average Receivables |
— | — | — | — | — | — | 3.62 | 10.55 | 16.69 | 22.30 |
Average Payables |
1.66 | 2.16 | 5.03 | 9.03 | 7.66 | 5.32 | 5.27 | 4.84 | 8.61 | 13.14 |
Average Inventory |
— | — | — | — | — | — | 1.51 | 5.77 | 13.68 | 22.25 |
Average Assets |
24.81 | 82.04 | 205.97 | 284.37 | 247.80 | 258.30 | 356.00 | 357.61 | 362.51 | 436.23 |
Average Common Equity |
(20.35) | 56.04 | 195.52 | 263.64 | 223.77 | 225.34 | 274.21 | 217.01 | 95.74 | 80.40 |
Columns are period end dates